Siemens showcases new clinical hardware, clinical applications

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The newly formed and renamed Siemens Medical Solutions Molecular Imaging division (formerly Siemens Nuclear Medicine Group) presented a vision of its entire molecular imaging portfolio including a new entry-level addition to its Symbia family of TruePoint SPECT-CT, a new attenuation correction feature to its c.cam gamma camera, and highlighted clinical applications at last week's 52nd Society of Nuclear Medicine (SNM) annual meeting in Toronto, Canada.
   
"We are talking about our new company and about molecular imaging in total," said Jonathan Frey, Director, Molecular Imaging Marketing. The company showed its "complete compendium" of nuclear medicine offerings and emphasized that they view themselves as the only vendor that provides a complete set of solutions for molecular imaging from pre-clinical, to clinical, to bio-markers, and that includes distribution, Frey added.
   
One side of Siemens' large booth focused on molecular imaging as a concept, the other side focused on products. The product side included a portion displaying what Frey called "clinical hardware."
   
Of the hardware, the new Symbia S, a SPECT-only offering is designed to provide medical facilities an entry to the molecular imaging area, with the option to upgrade to a range of attenuation correction, anatomical mapping, and CT options. The system's High-Definition Dynamic Digital Detectors (HD), Flash 3D technology, workflow automation feature, and user-friendly design allow for integration into a variety of clinical settings, Siemens said.
   
Siemens also demonstration the benefits of SPECT/CT, which is still a relatively new concept, showing it's benefits in bone scanning, cardiology scanning, and highlighted some clinical results from installations of the Symbia line to emphasize that diagnostic CT makes a difference in patients, Frey said.
   
Additionally in the hardware arena, the company showed an enhancement to its c.cam dedicated cardiac gamma camera called c.clear an attenuation correction feature designed to assist clinicians in overcoming unwanted objects or artifacts within an image. With c.clear, clinicians can remove or erase unwanted objects without a reduction in image quality or resolution.
   
Siemens' booth featured 16 workstations, with 40 syngo-based applications as well. Highlighted applications included TrueD which enables clinicians to do time-point imaging to compare pre-and- post scan analysis assisted by the software. Also highlighted was Scenium, an application which aids in neurological analysis.
    
On the education front, Siemens devoted a good deal of space to an educational area dubbed "Experience Molecular Imaging" designed around a few basic principles: preventing disease, diagnosing disease, therapeutics and care, and included an assortment of materials including videos in support. Also, they served coffee.